Predictors of HAV/HBV vaccination completion among methadone maintenance clients.
Author(s): Nyamathi A, Sinha K, Greengold B, Cohen A, Marfisee M
Affiliation(s): School of Nursing, University of California-Los Angeles, Box 951702, Los Angeles, CA 90095-1702, USA.
Publication date & source: 2010-04, Res Nurs Health., 33(2):120-32.
Publication type: Comparative Study; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
This randomized, controlled study (N = 256) was conducted to compare three interventions designed to promote hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination completion among clients undergoing methadone maintenance (MM) treatment. Participants were recruited from five MM treatment sites in Southern California and randomized into three groups: Motivational Interviewing-Single (MI-Single), Motivational Interviewing-Group (MI-Group); and Nurse-Led Hepatitis Health Promotion (HHP). All were offered the three-series HAV/HBV vaccine. A total of 148 participants completed the vaccine. Groups did not differ in rate of vaccination completion (73.6%, HHP group, vs. 65% and 69% for the MI-Single and MI-Group, respectively). The equivalence of findings across groups suggests the value of including nurses with a comprehensive health focus in promoting vaccination completion. (c) 2010 Wiley Periodicals, Inc.